SEC Comment Letter 0000000000-24-010193 to Journey Medical Corp (DERM)
Journey Medical Corp
Date: Sept. 9, 2024 · CIK: 0001867066 · Accession: 0000000000-24-010193
AI Filing Summary & Sentiment
File numbers found in text: 001-41063
Letter
September 9, 2024 Claude Maraoui Chief Executive Officer Journey Medical Corporation 9237 E Via de Ventura Blvd, Suite 105 Scottsdale, AZ 85258 Re:Journey Medical Corporation Form 10-K for the Fiscal Year Ended December 31, 2023 Filed March 29, 2024 File No. 001-41063 Dear Claude Maraoui: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Rakesh Gopalan, Esq.
Show Raw Text
September 9, 2024
Claude Maraoui
Chief Executive Officer
Journey Medical Corporation
9237 E Via de Ventura Blvd, Suite 105
Scottsdale, AZ 85258
Re:Journey Medical Corporation
Form 10-K for the Fiscal Year Ended December 31, 2023
Filed March 29, 2024
File No. 001-41063
Dear Claude Maraoui:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Rakesh Gopalan, Esq.